Market revenue in 2023 | USD 812.2 million |
Market revenue in 2030 | USD 1,692.1 million |
Growth rate | 11.1% (CAGR from 2023 to 2030) |
Largest segment | Pen injectors |
Fastest growing segment | Wearable injectors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors, Needle-free injectors |
Key market players worldwide | Gerresheimer AG ADR, Medtronic PLC, Ypsomed Holding AG, Novo Nordisk A/S ADR, Insulet Corp, Becton Dickinson & Co, West Pharmaceutical Services Inc, PHARMAJET, Unilife Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to subcutaneous drug delivery devices market will help companies and investors design strategic landscapes.
Pen injectors was the largest segment with a revenue share of 38.96% in 2023. Horizon Databook has segmented the Italy subcutaneous drug delivery devices market based on prefilled syringes, pen injectors, auto-injectors, wearable injectors, needle-free injectors covering the revenue growth of each sub-segment from 2018 to 2030.
Italy’s rapidly aging population and the growing proportion of individuals aged over 65 are some of the key factors expected to drive the subcutaneous drug delivery devices market growth. This demographic shift is significant as older adults often suffer from chronic diseases that require long-term medication adherence.
Moreover, demographic shifts, including a rising prevalence of chronic diseases, sustain the demand for drug delivery devices. According to the International Diabetes Federation's 2021 report, in Italy, out of a total adult population of 45,137,700, the prevalence of diabetes was 9.9%, which translates to approximately 4,470,300 cases of diabetes in adults.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy subcutaneous drug delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into Italy subcutaneous drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account